Emma Groarke: Evidence-Based Guidelines for the Management of Acquired Aplastic Anemia
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared American Society of Hematology’s post on LinkedIn:
“Excited to see these finally come to fruition!
We hope these will be helpful to patients and physicians dealing with aplastic anemia.
Was amazing to be part of this diverse guidelines panel of hematologists, transplanters, pediatricians, statisticians, methodologists, and of course patients.
Also the excellent ASH staff!
Special thanks to Phillip Scheinberg for taking this to ASH initially and driving it forward.”
American Society of Hematology shared a post on LinkedIn:
“ASH has released new clinical practice guidelines on the diagnosis and management of severe and very severe acquired aplastic anemia, a rare and life-threatening bone marrow disorder.
Developed by a multidisciplinary panel that included a patient perspective, these evidence-based recommendations are designed to support earlier and more accurate diagnosis, guide treatment decisions, and improve outcomes for children and adults living with this condition.
Learn more in the press release.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 05:38Doreen Su-Yin Tan։ Moving Toward Precision in Antiplatelet Therapy 2026 SCSASM2026 Highlights
-
Apr 20, 2026, 04:27Tareq Abadl: Can Vitamin C Trick a Glucose Reading?
-
Apr 20, 2026, 04:24Tagreed Alkaltham: Motivational Drivers of Voluntary Blood Donation
-
Apr 20, 2026, 01:13Konstantin Yenkoyan: Are We Targeting Alzheimer’s Disease at the Right Time and in the Right Place?
-
Apr 20, 2026, 00:59David McIntosh: The Vital Role of Blood and Plasma Donors in Medicine Supply
-
Apr 20, 2026, 00:38Strengthening Care in Burundi – WFH
-
Apr 20, 2026, 00:20Salih Ehsan: Why Are HbA2 Levels Stable in Thalassemia Minor During Severe Iron Deficiency?
-
Apr 20, 2026, 00:07Karen Zohrabyan: Honored to Be Speaking at CSI Frankfurt 2026
-
Apr 19, 2026, 15:59Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?